Mechanism of action
GLP-1 Receptor Agonism
Also called GLP-1 agonist, incretin mimetic
Mimicking the gut hormone GLP-1 to boost insulin, slow digestion and reduce appetite.
Medically reviewed by Dr. Jonathan Snipes, MD
Reviewed for clinical accuracy · Last reviewed July 22, 2026 · Review policy
Quick answer
GLP-1 receptor agonism means activating the receptor for glucagon-like peptide-1, a gut hormone released after eating. Doing so enhances glucose-dependent insulin release, slows gastric emptying, and reduces appetite, which is how drugs like semaglutide produce weight loss and glycemic control.
Key takeaways
- →GLP-1 is an incretin hormone released by the gut after meals; agonists mimic it.
- →Effects: more insulin when glucose is high, slower stomach emptying, and reduced appetite.
- →This is the best-validated weight and metabolic mechanism among peptide drugs.
- →Semaglutide is a pure GLP-1 agonist; tirzepatide adds a second (GIP) receptor.
What it is
GLP-1 (glucagon-like peptide-1) is an incretin hormone your gut releases after you eat. It tells the pancreas to release insulin, signals fullness to the brain, and slows how fast the stomach empties. A GLP-1 receptor agonist is a molecule that binds and activates the same receptor, reproducing those effects at a stronger and longer-lasting level than the natural hormone.
How it works
Three effects do most of the work. First, glucose-dependent insulin secretion: the drug boosts insulin release only when blood glucose is elevated, which lowers glucose without causing as much hypoglycemia. Second, delayed gastric emptying, so food stays in the stomach longer and you feel full sooner. Third, central appetite suppression through receptors in the brain. Together these reduce food intake and improve glucose control, which is why this mechanism underpins both diabetes and weight-management drugs.
Compounds that use this mechanism
Semaglutide
FDA-approved GLP-1 receptor agonist for type 2 diabetes and chronic weight management.
Tirzepatide
FDA-approved dual GIP/GLP-1 receptor agonist with the highest weight-loss results of any approved medication.
Frequently asked questions
What does a GLP-1 agonist do?+
It activates the GLP-1 receptor to increase glucose-dependent insulin release, slow gastric emptying, and reduce appetite, lowering blood sugar and driving weight loss.
Which drugs are GLP-1 agonists?+
Semaglutide (Ozempic, Wegovy, Rybelsus) is a pure GLP-1 agonist. Tirzepatide (Mounjaro, Zepbound) is a dual agonist that also activates the GIP receptor.
Sources
- 1.Drugs@FDA: FDA-Approved Drugs database · U.S. Food & Drug Administration